Dutch Crucell’s new flu vaccine may outperform Roche’s Tamiflu
LONDON An experimental flu vaccine might work better than Roche’s Tamiflu, according to preclinical testing data.
The drug, an antibody by Dutch biotech company Crucell designated mAb CR6261, was shown to outperform Tamiflu (oseltamivir phosphate) when tested against several strains of the flu, including the deadly H5N1 avian influenza, though it has yet to enter clinical testing.
Crucell presented data in San Diego at a conference on antibody engineering.
Rite Aid upgrades cash registers to support FSA cards
CAMP HILL, Pa. Rite Aid has upgraded its pharmacy and front-end cash registers to make it easier for shoppers to use their Flexible Spending Account debit cards.
The pharmacy retailer is utilizing an inventory information approval system to allow customers to pay for eligible healthcare items with FSA debit cards. Eligible healthcare purchases on receipts are identified with an H to the right of the item’s price. These items are tallied by the cash register and can be paid for by an FSA debit card. The remaining balance for non-eligible items is paid for separately.
The FSA debits cards work similar to other debit cards and allow customers to buy certain health items using funds from a pre-tax accounts.
FDA delays approval of Remoxy painkiller
NEW YORK The Food and Drug Administration announced that it needed more clinical studies of the pain pill Remoxy before it would approve it.
The pill, a formulation of oxycodone by King Pharmaceuticals and Pain Therapeutics, is designed in a capsule form that prevents abuse by people trying to get high.
On Wednesday, King Pharmaceuticals’ shares were down by 83 cents, at $9.13, and Pain Therapeutics were down by $1.82, at $5.93.